Glaxo Buys Sirtris, SIRT +10.02 (+81.93%)
Congratulations to any long-term resveratrol-eating holders of SIRT stock, which I’ve mentioned many times before, as your portfolio should be up nicely today with a buyout and almost doubling in stock price.
I had some stock for a moment in December, but was stopped out. From a technical perspective, things didn’t look great when it made a new all-time low in March. But things look pretty good today, with a last and final all-time high.
